Xiaorong Zhou

3.0k citations
120 papers · 2.2k indexed · h-index 27
Topics
Immune Cell Function and Interaction (13 papers)RNA modifications and cancer (12 papers)Ferroptosis and cancer prognosis (12 papers)

In The Last Decade

Xiaorong Zhou

110 papers receiving 2.2k citations

Peers

Xiaorong Zhou
Comparison fields: 5 of 127
  • Molecular Biology 976
  • Immunology 597
  • Cardiology and Cardiovascular Medicine 321
  • Cancer Research 272
  • Oncology 221
Replace Chang-Hoon Woo with:
Chang-Hoon Woo South Korea
Guey-Yueh Shi Taiwan
Suresh Mishra Canada
Qingbo Xu Austria
David Schmitt United States
Xianghong Zhang China
Sohsuke Yamada Japan
Suk‐Hwan Baek South Korea
Jun Hee Lee South Korea
James S. Owen United Kingdom
Xiaorong Zhou relative to Chang-Hoon Woo South Korea Chang-Hoon Woo's profile →
Citations per field
00.5×4.6×
Chang-Hoon Woo · 1×
Citations per year

Countries citing papers authored by Xiaorong Zhou

Since Specialization
Citations

This map shows the geographic impact of Xiaorong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaorong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaorong Zhou more than expected).

Fields of papers citing papers by Xiaorong Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaorong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaorong Zhou. The network helps show where Xiaorong Zhou may publish in the future.

Co-authorship network of co-authors of Xiaorong Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaorong Zhou. A scholar is included among the top collaborators of Xiaorong Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaorong Zhou. Xiaorong Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 2
4 2
5 3
6 3
7 2
8 5
9 6
10 1
11 6
12 9
13 3
14 17
15 19
16 22
17 20
18 35
19 23
20 56

About Xiaorong Zhou

Xiaorong Zhou is a scholar working on Immunology, Immunology and Allergy and Cancer Research, having authored 120 papers that have together received 2.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), RNA modifications and cancer (12 papers) and Ferroptosis and cancer prognosis (12 papers). The work is most often cited by research in Immunology (597 citations), Clinical Biochemistry (167 citations) and Cancer Research (272 citations). Xiaorong Zhou has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Eric J. Topol, Marc S. Penn, Bao‐Ping Pang, Zhongmin Zhou, Stanley L. Hazen, Farhad Forudi, A. Michael Lincoff, Xiaoling Ding, Kathryn A. O’Donnell and Annitta Morehead. Their work appears in journals such as Nucleic Acids Research, Circulation and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026